Chloroquine phosphate
- Product NDC
- 76385-142
- 11-digit product format
- 763850142
- Labeler code
- 76385
- Product ID
- 76385-142_d961e77e-ad7c-4663-e053-2a95a90a2410
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- Chloroquine phosphate
- Dosage form
- TABLET, FILM COATED
- Route
- ORAL
- Labeler
- Bayshore Pharmaceuticals LLC
- Application
- ANDA090610
- Marketing category
- ANDA
- Marketing start
- 2020-04-15
- Marketing end
- 0000-00-00
- Substance
- CHLOROQUINE PHOSPHATE
- Active strength
- 250 mg/1
- Pharmacologic classes
- Antimalarial [EPC]
- NDC exclude flag
- No
- Listing certified through
- 2023-12-31
- Current FDA listing
- Historical FDA.report record
NDC auxiliary status#
Explicit status records from FDA unfinished, excluded, and compounder auxiliary files. Absence of a row is not itself a regulatory status.
Dataset, Scope, Product NDC table| Dataset | Scope | Product NDC | Package NDC | Code | Status | Reporting period | Source date |
|---|
| excluded product | product | 76385-142 | | D | Discontinued by firm | | 2026-07-31 |
| excluded package | package | 76385-142 | 76385-142-05 | D | Discontinued by firm | | 2026-07-31 |
Orange Book products#
Application-product, Trade name, Ingredient table| Application-product | Trade name | Ingredient | Strength | Dosage form / route | TE codes | RLD / RS | Approval date |
|---|
| A090610-001 | CHLOROQUINE PHOSPHATE | CHLOROQUINE PHOSPHATE | 250MG | TABLET / ORAL | | | 2009-12-03 |
Packages#
Package NDC, 11-digit format, Description table| Package NDC | 11-digit format | Description | Marketing start | Marketing end | Sample | Exclude flag | Status |
|---|
| 76385-142-05 | 76385014205 | 50 TABLET, FILM COATED in 1 BOTTLE (76385-142-05) | 2020-04-15 | 0000-00-00 | No | No | Current |